ASTAMARINE Trademark

Trademark Overview


On Monday, June 10, 2013, a trademark application was filed for ASTAMARINE with the United States Patent and Trademark Office. The USPTO has given the ASTAMARINE trademark a serial number of 85954765. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 13, 2024. This trademark is owned by PIVEG, INC.. The ASTAMARINE trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements; Dietary and nutritional supplements containing astaxanthin; Dietary food supplements; Dietary supplements; Dietary supplements for human consumption; Dietary supplements for treatment of cardiovascular, immnue, inflammatory and neurodegenerative diseases, and sun-exposure damage; Food supplements; Food supplements for treatment of cardiovascular, immnue, inflammatory and neurodegenerative diseases, and sun-exposure damage; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treatment of cardiovascular, immnue, inflammatory and neurodegenerative diseases, and sun-exposure damage; Nutritional supplements; Nutritional supplements for treatment of cardiovascular, immnue, inflammatory and neurodegenerative diseases, and sun-exposure damage; Vitamin and mineral supplements; Vitamin supplements
astamarine

General Information


Serial Number85954765
Word MarkASTAMARINE
Filing DateMonday, June 10, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 13, 2024
Registration Number4542175
Registration DateTuesday, June 3, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2014

Trademark Statements


Goods and ServicesDietary and nutritional supplements; Dietary and nutritional supplements containing astaxanthin; Dietary food supplements; Dietary supplements; Dietary supplements for human consumption; Dietary supplements for treatment of cardiovascular, immnue, inflammatory and neurodegenerative diseases, and sun-exposure damage; Food supplements; Food supplements for treatment of cardiovascular, immnue, inflammatory and neurodegenerative diseases, and sun-exposure damage; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treatment of cardiovascular, immnue, inflammatory and neurodegenerative diseases, and sun-exposure damage; Nutritional supplements; Nutritional supplements for treatment of cardiovascular, immnue, inflammatory and neurodegenerative diseases, and sun-exposure damage; Vitamin and mineral supplements; Vitamin supplements
Translation of Words in MarkThe wording "Astamarine" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 13, 2024
Primary Code005
First Use Anywhere DateMonday, May 20, 2013
First Use In Commerce DateMonday, May 20, 2013

Trademark Owner History


Party NamePIVEG, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NamePIVEG, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NamePIVEG, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Friday, June 14, 2013TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, June 13, 2013NEW APPLICATION ENTERED
Tuesday, January 7, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 14, 2013TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, June 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 20, 2013ASSIGNED TO EXAMINER
Tuesday, September 24, 2013NON-FINAL ACTION WRITTEN
Tuesday, September 24, 2013NON-FINAL ACTION E-MAILED
Tuesday, September 24, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 6, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 6, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 7, 2014TEAS AMENDMENT OF USE RECEIVED
Saturday, February 8, 2014USE AMENDMENT ACCEPTED
Saturday, February 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 11, 2014NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, February 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2014ASSIGNED TO LIE
Friday, January 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 5, 2014USE AMENDMENT FILED
Wednesday, February 5, 2014AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, February 12, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 3, 2014REGISTERED-PRINCIPAL REGISTER
Monday, June 3, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 11, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 18, 2014PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020TEAS SECTION 8 & 15 RECEIVED
Saturday, June 3, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 13, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, June 11, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, June 11, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.